Drug Type Small molecule drug |
Synonyms- |
Mechanism AChE inhibitors(Acetylcholinesterase inhibitors), AKR1B1 inhibitors(Aldose reductase inhibitors), BChE inhibitors(Butyrylcholinesterase inhibitors) + [2] |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | TR | 21 May 2024 | |
Diabetes Mellitus | Preclinical | TR | 21 May 2024 | |
Epilepsy | Preclinical | TR | 21 May 2024 | |
Glaucoma | Preclinical | TR | 21 May 2024 | |
Neuropathy | Preclinical | TR | 21 May 2024 |